BRCA genes as candidates for colorectal cancer genetic testing panel: systematic review and meta-analysis
Open Access
- 29 August 2023
- journal article
- review article
- Published by Springer Nature in BMC Cancer
- Vol. 23 (1) , 1-10
Abstract
Background: Breast cancer susceptibility gene (BRCA) mutation carriers are at an increased risk for breast, ovarian, prostate and pancreatic cancers. However, the role of BRCA is unclear in colorectal cancer; the results regarding the association between BRCA gene mutations and colorectal cancer risk are inconsistent and even controversial. This study aimed to investigate whether BRCA1 and BRCA2 gene mutations are associated with colorectal cancer risk. Methods: In this systematic review, we searched PubMed/MEDLINE, Embase and Cochrane Library databases, adhering to PRISMA guidelines. Study quality was assessed using the Newcastle–Ottawa Scale (NOS). Unadjusted odds ratios (ORs) were used to estimate the probability of Breast Cancer Type 1 Susceptibility gene (BRCA1) and Breast Cancer Type 2 Susceptibility gene (BRCA2) mutations in colorectal cancer patients. The associations were evaluated using fixed effect models. Results: Fourteen studies were included in the systematic review. Twelve studies, including seven case–control and five cohort studies, were included in the meta-analysis. A significant increase in the frequency of BRCA1 and BRCA2 mutations was observed in patients with colorectal cancer [OR = 1.34, 95% confidence interval (CI) = 1.02–1.76, P = 0.04]. In subgroup analysis, colorectal cancer patients had an increased odds of BRCA1 (OR = 1.48, 95% CI = 1.10–2.01, P = 0.01) and BRCA2 (OR = 1.56, 95% CI = 1.06–2.30, P = 0.02) mutations. Conclusions: BRCA genes are one of the genes that may increase the risk of developing colorectal cancer. Thus, BRCA genes could be potential candidates that may be included in the colorectal cancer genetic testing panel.Keywords
Funding Information
- Beijing Municipal Administration of Hospitals’ Youth Program (QMS20220131)
- Beijing Municipal Administration of Hospitals Incubating Program (PX2022002)
- Research Foundation of Beijing Friendship Hospital (YYQDKT2019-21)
- Natural Science Foundation of Beijing Municipality (L222149)
This publication has 53 references indexed in Scilit:
- BRCA1 mutations and colorectal cancer in PolandFamilial Cancer, 2010
- BRCA1 and its toolbox for the maintenance of genome integrityNature Reviews Molecular Cell Biology, 2009
- Cancer risks in carriers of the BRCA1/2 Ashkenazi founder mutationsJournal of Medical Genetics, 2007
- Characterization ofBRCA1andBRCA2Mutations in a Large United States SampleJournal of Clinical Oncology, 2006
- BRCA1 and BRCA2: 1994 and beyondNature Reviews Cancer, 2004
- Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 StudiesThe American Journal of Human Genetics, 2003
- Cancer Incidence in BRCA1 Mutation CarriersJNCI: Journal of the National Cancer Institute, 2002
- Roles of BRCA1 and its interacting proteinsBioEssays, 2000
- Risks of cancer in BRCA1-mutation carriersThe Lancet, 1994
- Linkage of Early-Onset Familial Breast Cancer to Chromosome 17q21Science, 1990